118 related articles for article (PubMed ID: 14981028)
21. Digoxin and its related endogenous factors.
Jortani SA; Valdes R
Crit Rev Clin Lab Sci; 1997; 34(3):225-74. PubMed ID: 9226105
[TBL] [Abstract][Full Text] [Related]
22. Methods for eliminating interferences in digoxin immunoassays caused by digoxin-like factors.
Graves SW; Sharma K; Chandler AB
Clin Chem; 1986 Aug; 32(8):1506-9. PubMed ID: 3755385
[TBL] [Abstract][Full Text] [Related]
23. Improved interassay correlation of digoxin results in patients with and without renal failure by elimination of digoxin-like immunoreactive factors.
Skogen WF; Rea MR; Valdes R
Clin Chem; 1987 Jun; 33(6):837-9. PubMed ID: 3594830
[TBL] [Abstract][Full Text] [Related]
24. Endogenous digoxin-like immunoreactivity in blood is increased during prolonged strenuous exercise.
Valdes R; Hagberg JM; Vaughan TE; Lau BW; Seals DR; Ehsani AA
Life Sci; 1988; 42(1):103-10. PubMed ID: 3336270
[TBL] [Abstract][Full Text] [Related]
25. Insulin-like growth factor I enhancement of steroidogenesis by bovine granulosa cells and thecal cells: dependence on de novo cholesterol synthesis.
Spicer LJ; Hamilton TD; Keefer BE
J Endocrinol; 1996 Dec; 151(3):365-73. PubMed ID: 8994382
[TBL] [Abstract][Full Text] [Related]
26. Digitalis-like factor and digoxin-like immunoreactive factor in diabetic women with preeclampsia, transient hypertension of pregnancy, and normotensive pregnancy.
Graves SW; Lincoln K; Cook SL; Seely EW
Am J Hypertens; 1995 Jan; 8(1):5-11. PubMed ID: 7734097
[TBL] [Abstract][Full Text] [Related]
27. Endogenous digoxin-like immunoreactive factor (DLIF) serum concentrations are decreased in manic bipolar patients compared to normal controls.
Grider G; El-Mallakh RS; Huff MO; Buss TJ; Miller J; Valdes R
J Affect Disord; 1999 Aug; 54(3):261-7. PubMed ID: 10467969
[TBL] [Abstract][Full Text] [Related]
28. Dialyzability and binding of digoxin-like immunoreactive factors (DLIF) with serum macromolecules in uremic patients on hemodialysis.
Dasgupta A; Peng Y
Life Sci; 1991; 49(22):1603-9. PubMed ID: 1943464
[TBL] [Abstract][Full Text] [Related]
29. Identification and preliminary characterization of two human digitalis-like substances that are structurally related to digoxin and ouabain.
Weinberg U; Dolev S; Werber MM; Shapiro MS; Shilo L; Shenkman L
Biochem Biophys Res Commun; 1992 Nov; 188(3):1024-9. PubMed ID: 1445339
[TBL] [Abstract][Full Text] [Related]
30. Digoxin-like immunoreactive factor(s) in human gonadotropin stimulated follicular fluid.
Jakobi P; Krivoy N; Eibschitz I; Ziskind G; Barzilai D; Paldi E
J Clin Endocrinol Metab; 1989 Jul; 69(1):209-11. PubMed ID: 2499591
[TBL] [Abstract][Full Text] [Related]
31. Excretion of endogenous digoxin-like immunoreactive factors in human urine is a function of urine flow rate.
Siegfried BA; Valdes R
Clin Chem; 1988 May; 34(5):960-4. PubMed ID: 3370798
[TBL] [Abstract][Full Text] [Related]
32. A mechanism for the in vitro stimulation of adrenal cortisol biosynthesis by epidermal growth factor.
Singh-asa P; Waters MJ; Wilce PA
Int J Biochem; 1985; 17(8):857-62. PubMed ID: 2995161
[TBL] [Abstract][Full Text] [Related]
33. An endogenous digitalis-like factor derived from the adrenal gland: studies of adrenal tissue from various sources.
Doris PA; Stocco DM
Endocrinology; 1989 Nov; 125(5):2573-9. PubMed ID: 2791999
[TBL] [Abstract][Full Text] [Related]
34. Serum digoxin-like immunoreactive factor in children and its relation to sodium metabolism.
Garbagnati E
Acta Paediatr; 1998 May; 87(5):500-4. PubMed ID: 9641729
[TBL] [Abstract][Full Text] [Related]
35. Digoxin and digoxin-like immunoreactive factors (DLIF) modulate the release of pro-inflammatory cytokines.
Ihenetu K; Espinosa R; de Leon R; Planas G; Perez-Pinero A; Waldbeser L
Inflamm Res; 2008 Nov; 57(11):519-23. PubMed ID: 19109744
[TBL] [Abstract][Full Text] [Related]
36. Mammalian bufadienolide is synthesized from cholesterol in the adrenal cortex by a pathway that Is independent of cholesterol side-chain cleavage.
Dmitrieva RI; Bagrov AY; Lalli E; Sassone-Corsi P; Stocco DM; Doris PA
Hypertension; 2000 Sep; 36(3):442-8. PubMed ID: 10988279
[TBL] [Abstract][Full Text] [Related]
37. The role of substrate supply in the regulation of cholesterol biosynthesis in rat hepatocytes.
Pullinger CR; Gibbons GF
Biochem J; 1983 Mar; 210(3):625-32. PubMed ID: 6870798
[TBL] [Abstract][Full Text] [Related]
38. [Determination of endoxin in hypertensive patients].
Gorjão Clara J; Breitenfeld B; Bicho M; Moreira C; Carvalho C; Boaventura I; Manso C; Nogueira da Costa J
Rev Port Cardiol; 1991 Jan; 10(1):29-33. PubMed ID: 1647807
[TBL] [Abstract][Full Text] [Related]
39. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.
Lennernäs H; Fager G
Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173
[TBL] [Abstract][Full Text] [Related]
40. B-Type natriuretic peptide inhibited angiotensin II-stimulated cholesterol biosynthesis, cholesterol transfer, and steroidogenesis in primary human adrenocortical cells.
Liang F; Kapoun AM; Lam A; Damm DL; Quan D; O'Connell M; Protter AA
Endocrinology; 2007 Aug; 148(8):3722-9. PubMed ID: 17478552
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
